Stories about physicians and other healthcare professionals involved in lawsuits—as either a plaintiff or a defendant—or accused of breaking the law. Various legal updates or unusual stories in the news may land here.
Timothy Story, MD, said Ascension St. Vincent Medical Center damaged his career and reputation after they fired him without cause. After a three-and-a-half year legal trial, a jury in Indiana agreed.
The world's largest generic drug manufacturer allegedly paid charities kickbacks to cover patient co-pays in an effort to inflate the price tag of its multiple sclerosis treatment.
The groups are urging the Supreme Court to uphold a lower court ruling in Garland v. VanDerStok that permits the ATF to regulate firearms made from part kits.
The agency has received an increasing number of complaints from patients enrolled in a low-value health plan without their knowledge. If finalized, a new rule would empower CMS to ban brokers from the ACA marketplace.
The suit, which includes multiple accusations of malpractice and dishonest behavior, is just the latest chapter of a story that has been making headlines for years.
Assembly Bill 3129 would have given the California Attorney General oversight of all private equity investments or purchases involving a healthcare entity. Gov. Gavin Newsom argued that a similar regulatory framework is already in place.
A federal judge in California ruled existing evidence of the negative effects of fluoride in drinking water warrants an investigation and potential action from the Environmental Protection Agency.
Particle Health has accused Epic Systems of monopolistic business practices that hinder data-driven initiatives to improve patient care. Epic calls the complaint “baseless.”
AB 3129 grants the Attorney General of California oversight of private equity transactions in healthcare. An attorney with Holland & Knight is concerned about the unintended consequences of the proposed law.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.